Sorry, you need to enable JavaScript to visit this website.

The novel Coronavirus disease (COVID-19) has been the most critical global challenge over the past months. Lung involvement quantification and distinguishing the types of infections from chest CT scans can assist in accurate severity assessment of COVID-19 pneumonia, efficient use of limited medical resources, and saving more lives. Nevertheless, visual assessment of chest CT images and evaluating the disease severity by radiologists are expensive and prone to error.